Alexion Pharmaceuticals (ALXN) News Today → A new way to collect income from stocks (From DTI) (Ad) Free ALXN Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineAlexion’s Voydeya gains FDA approval for extravascular haemolysismsn.com - April 2 at 1:31 PMUS FDA grants approval for Alexion’s NMOSD treatmentmsn.com - March 27 at 7:22 AMJCR Pharmaceuticals Announces Achievement of Milestone Using J-Brain Cargo® Technology for Neurodegenerative Disease in Research Collaboration with Alexionbusinesswire.com - March 19 at 7:37 AMCitius Pharmaceuticals (CTXR) Earnings Watch: Pharma Stock Signals for Investorsstocknews.com - December 11 at 9:06 PMLevi & Korsinsky, LLP Notifies Shareholders of Alexion Pharmaceuticals, Inc. (ALXN) an Upcoming Claims Deadline in a Class Action Settlementmarkets.businessinsider.com - December 8 at 3:39 PMBioMarin Pharma gains on report Elliott has a stakeinvesting.com - November 7 at 2:16 PMGilead Sciences (GILD) Earnings Forecast and Gameplanstocknews.com - November 6 at 11:05 PMAlexion and Verge enter AI-powered drug discovery dealmsn.com - September 11 at 7:27 AMAlexion Pharmaceuticals Inc (A1LX34)investing.com - May 13 at 1:57 AMWilson Disease Drugs Market Size, Growth Strategies, Gross Margin and Forecast 2029marketwatch.com - April 25 at 3:40 PMAlexion Reaches New 52-Week High (ALXN)thestreet.com - April 10 at 12:29 AMAlexion advances commitment to transform patient outcomes in rare neurological diseases at AAN 2023stockhouse.com - March 4 at 6:07 PMAstraZeneca goes for growth with new drugs as COVID sales waneinvesting.com - February 9 at 8:37 AMHealthcare Sector Is Lagging As We Enter 2022 Earnings Seasonseekingalpha.com - January 25 at 1:39 AMSynageva Biopharma (GEVA) Stock More Than Doubles to 52-Week High on Alexion Acquisitionthestreet.com - January 21 at 10:19 AMAlexion aims to advance NMOSD treatment landscape with exceptional ULTOMIRIS® (ravulizumab-cwvz) efficacy data at ECTRIMS 2022finance.yahoo.com - October 14 at 8:29 AMUS close: Dow loses almost 1,300 points after hot CPI readinglse.co.uk - September 15 at 8:48 PMAlexion Stock Hits New 52-Week High (ALXN)thestreet.com - September 1 at 7:00 PMFTSE 100 positive but off best levels, US seen higheruk.investing.com - July 29 at 11:11 AMAstraZeneca's Unit Alexion To Pay $775 Mln To Chugai On Ultomiris Patent Settlementmarkets.businessinsider.com - March 17 at 4:35 PMAstraZeneca inks $760 million deal with Swiss firm Neurimmune for antibody druguk.investing.com - March 1 at 6:02 AMUK pre-market stocks update – Shell, AstraZeneca, Aston Martin, C&Cmsn.com - January 7 at 8:05 AMWas The Smart Money Right About Piling Into Microchip Technology Incorporated (MCHP)?finance.yahoo.com - November 8 at 1:55 PMSHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Alexion Pharmaceuticals, Inc. (ALXN)finance.yahoo.com - October 26 at 12:22 AMAstraZeneca Buys Fortress-Biotech Founded Caelum For $500Mfeeds.benzinga.com - September 29 at 9:47 AMAstraZeneca buys rare disease drugmaker Caelum in potential $500 mln dealfinancialpost.com - September 29 at 5:45 AMAlexion Must Face Claims Of Stalling On Drug After Mergerlaw360.com - September 3 at 1:31 AMWere Hedge Funds Right About Alexion Pharmaceuticals, Inc. (ALXN)?finance.yahoo.com - August 9 at 2:07 PMAlexion Pharmaceuticals Inc ALXN-MXcnbc.com - July 24 at 10:08 PMAstraZeneca Wraps Its Massive Alexion Buyout — Is AZN Stock A Buy Or Sell?finance.yahoo.com - July 23 at 3:38 PMAlexion Pharmaceuticals (ALXN) Earnings Expected to Grow: Should You Buy?finance.yahoo.com - July 22 at 5:32 PM Get Alexion Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ALXN and its competitors with MarketBeat's FREE daily newsletter. Email Address One trade. One ticker. One week. (Ad)Do you want to target weekly income of up to $2k or more… Starting with just $500... With just one trade per week? Well, then you should click here to see this free training. ALXN Media Mentions By Week ALXN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ALXN News Sentiment▼0.490.43▲Average Medical News Sentiment ALXN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ALXN Articles This Week▼00▲ALXN Articles Average Week Get Alexion Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ALXN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ALNY News BMRN News RPRX News UTHR News CTLT News REGN News VRTX News TAK News GMAB News TEVA News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ALXN) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alexion Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
